PRRT2 and neoplasm: Accumulating evidence suggests that iCCA features a dense stromal reaction and complex tumor immune microenvironment, composed of immune cells, cancer-associated fibroblasts (CAFs), and tumor-associated macrophages (TAMs) involved in tumor progression [2, 3].